Friday 30 October 2020
Home      All news      Contact us      RSS     
healtheuropa - 3 month ago

First at-home treatment for spinal muscular atrophy approved by FDA

The first at-home, orally administered treatment for spinal muscular atrophy has been approved by the US Food and Drug Administration (FDA). The treatment – Evrysdi (risdiplam) – has shown improvements in motor function and obtainment of developmental milestones across two trials in patients age two months and above and across all levels of disease severity, [ ] The post First at-home treatment for spinal muscular atrophy approved by FDA appeared first on Health Europa.


Latest News
Hashtags:   

First

 | 

treatment

 | 

spinal

 | 

muscular

 | 

atrophy

 | 

approved

 | 

Sources